Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
25 studies found for:    Open Studies | "Acromegaly"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Treatment Patterns and Treatment Outcomes for Acromegaly
Condition: Acromegaly
Intervention:
2 Not yet recruiting The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research
Condition: Acromegaly
Interventions: Procedure: Transnasal butterfly surgery;   Drug: sandostatin;   Radiation: radiotherapy
3 Recruiting A Prospective Study of Outcome After Therapy for Acromegaly
Condition: Acromegaly
Interventions: Procedure: Surgery for acromegaly;   Drug: Medications for acromegaly
4 Recruiting Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide capsules;   Drug: Injectable Somatostatin Analogs (octreotide or lanreotide);   Drug: Cabergoline
5 Not yet recruiting Strict IGF-1 Control in Acromegaly
Condition: Acromegaly
Intervention: Drug: Pegvisomant
6 Recruiting Developing a Simple Recognition System of Acromegaly
Condition: Acromegaly
Intervention:
7 Recruiting Late Effects of Radiosurgery on Acromegaly Study
Condition: Acromegaly
Intervention: Device: Gamma Knife radiosurgery
8 Recruiting IGF-I and Free Fatty Acids Isn Glucose Metabolism in Acromegaly
Condition: Acromegaly
Intervention:
9 Recruiting Assessment of Airway in Patients With Acromegaly for Predicting Successful Tracheal Intubation
Condition: Acromegaly
Intervention: Device: Fiberoptic
10 Recruiting Assessment of Changes in Metabolic Activity in Liver & Skeletal Muscle in Patients Suffering From Acromegaly
Condition: Acromegaly
Interventions: Other: 1H/31P Magnetic Resonance Spectroscopy;   Other: oral glucose tolerance testing;   Other: Thyroid sonography
11 Recruiting Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly
Condition: Acromegaly
Intervention: Drug: BIM23B065
12 Recruiting Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly
Condition: Acromegaly
Intervention: Drug: Lanreotide PRF
13 Not yet recruiting Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly Cardiomyopathy
Condition: Acromegaly Cardiomyopathy
Intervention: Drug: Tadalafil
14 Recruiting Acromegaly Combination Treatment Study
Condition: Acromegaly
Interventions: Drug: Pegvisomant;   Drug: Somatostatin Receptor Ligand (SRL)
15 Recruiting Cardiac (CMRI) Assessment of Acromegaly
Condition: Acromegaly
Interventions: Device: CMRI;   Drug: Gadolinium;   Procedure: OGTT
16 Recruiting The Treatment and Natural History of Acromegaly
Conditions: Acromegaly;   Pituitary Neoplasm
Intervention:
17 Recruiting Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
Conditions: Cushing's Disease;   Acromegaly
Interventions: Drug: Pasireotide s.c.;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Insulin;   Drug: Pasireotide LAR;   Drug: Metformin
18 Recruiting Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects
Condition: Acromegaly
Intervention:
19 Recruiting Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues
Condition: Acromegaly
Intervention: Drug: Sandostatin (Octreotide Acetate)
20 Recruiting Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment
Conditions: Acromegaly;   Excessive Growth Hormone Secretion;   Insulin Resistance
Intervention: Procedure: Transsphenoidal adenomectomy

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.